<PAGE>
FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Medicode, Inc.
- --------------------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
Utah before reincorporation, Delaware after reincorporation 87-0459623
- --------------------------------------------------------------------------------
(State of incorporation or organization) (IRS Employer
I.D. No.)
5225 Wiley Post Way, Suite 500, Salt Lake City, Utah 84116
- --------------------------------------------------------------------------------
(Address of principal executive offices)
Securities to be registered pursuant to Section 12(b) of the Act:
NONE
- --------------------------------------------------------------------------------
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, $0.001 par value
- --------------------------------------------------------------------------------
<PAGE>
Item 1. Description of Registrant's Securities to be Registered
-------------------------------------------------------
Incorporated by reference to pages 44 through 45 of the Preliminary
Prospectus, contained in Registrant's Registration Statement on
Form S-1 filed on September 24, 1997 (the "S-1 Registration
Statement").
Item 2. Exhibits
--------
The following exhibits are filed as a part of this registration
statement:
1.* Specimen certificate for Registrant's Common Stock;
2.** Articles of Incorporation, as currently in effect;
3.*** Form of Certificate of Incorporation, as in effect immediately
following reincorporation.
4.**** Form of Restated Certificate of Incorporation to be filed after
the closing of the offering made under the S-1 Registration
Statement.
__________________
* Incorporated by reference to Exhibit 4.1 to the S-1 Registration Statement.
** Incorporated by reference to Exhibit 3.1 to the S-1 Registration Statement.
*** Incorporated by reference to Exhibit 3.2 to the S-1 Registration
Statement.
**** Incorporated by reference to Exhibit 3.3 to the S-1 Registration Statement.
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has duly caused this Registration Statement to be signed
on its behalf by the undersigned, thereto duly authorized.
Date: September 24, 1997
MEDICODE, INC.
By: /s/ KEVIN W. PEARSON
----------------------------------------
Kevin W. Pearson, Chief Financial Officer
-3-
